Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
Download PDF
Synthesis 2024; 56(03): 462-468
DOI: 10.1055/a-2202-5597
DOI: 10.1055/a-2202-5597
paper
A Convergent Approach for the Synthesis of C14–C26 Fragment of Anticancer Drug Eribulin Mesylate
Authors
The authors thanks CSIR, New Delhi for funding this project under mission INPROTICS.
Abstract
The stereoselective synthesis of C14–C26 fragment of eribulin is reported in a convergent way by coupling of fragment C14–C19 with fragment C20–C26 that are accessible from commercially available raw materials crotonic acid and 1,4-butanediol. The key steps involved in this practical approach are Hosomi–Sakurai asymmetric alkylation, Maruoka allylation, Noyori reduction, silver-catalyzed one-pot rearrangement, and intramolecular cyclization.
Supporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/a-2202-5597.
- Supporting Information (PDF)
Publication History
Received: 01 August 2023
Accepted after revision: 02 November 2023
Accepted Manuscript online:
02 November 2023
Article published online:
29 November 2023
© 2023. Thieme. All rights reserved
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1a Uemura D, Takahashi K, Yamamoto T, Katayama C, Tanaka J, Okumura Y, Hirata Y. J. Am. Chem. Soc. 1985; 107: 4796
- 1b Hirata Y, Uemura D. Pure Appl. Chem. 1986; 58: 701
- 2a Yu MJ, Zheng W, Seletsky BM, Littlefield BA, Kishi Y. Annual Reports in Medicinal Chemistry, Vol. 46, Chap. 14. Macor JE. Academic Press; New York: 2011: 227
- 2b Dybdal-Hargreaves NF, Risinger AL, Mooberry SL. Clin. Cancer Res. 2015; 21: 2445
- 2c Swami U, Shah U, Goel S. Mar. Drugs 2015; 13: 5016
- 2d Jimeno A. Clin. Cancer Res. 2009; 15: 3903
- 2e Preston JN, Trivedi MV. Ann. Pharmacother. 2012; 46: 802
- 3a Stamos DP, Chen SS, Kishi Y. J. Org. Chem. 1997; 62: 7552
- 3b Chase CE, Fang FG, Lewis BM, Wilkie GD, Schnaderbeck MJ, Zhu X. Synlett 2013; 24: 323
- 3c Austad BC, Benayoud F, Calkins TL, Campagna S, Chase CE, Choi H.-W, Christ W, Costanzo R, Cutter J, Endo A, Fang FG, Hu Y, Lewis BM, Lewis MD, MeKenna S, Noland TA, Orr JD, Peasant M, Schnaderbeck MJ, Wilkie GD, Abe T, Asai N, Asai Y, Kayano A, Kimoto Y, Komastsu Y, Kubota M, Kuroda H, Mizuno M, Nakamura T, Omae T, Ozeki N, Suzuki T, Takigawa T, Watanabe T, Yoshizawa K. Synlett 2013; 24: 327
- 3d Austad BC, Calkins TL, Chase CE, Fang FG, Horstmann TE, Hu Y, Lewis BM, Niu X, Noland TA, Orr JD, Schnaderbeck MJ, Zhang H, Asakawa N, Asai N, Chiba H, Hasebe T, Hoshino Y, Ishizuka H, Kajima T, Kayano A, Komastsu Y, Kubota M, Kuroda H, Miyazawa M, Tagami K, Watanabe T. Synlett 2013; 24: 333
- 3e Lee JH, Kishi Y. J. Am. Chem. Soc. 2016; 138: 7178
- 3f Lee JH, Li Z, Osawa A, Kishi Y. J. Am. Chem. Soc. 2016; 138: 16248
- 4a Lavanya N, Kiranmai N, Mainkar PS, Chandrasekhar S. Tetrahedron Lett. 2015; 56: 4283
- 4b Lee JH, Li Zh, Osawa A, Kishi Y. J. Am. Chem. Soc. 2016; 138: 16248
- 4c Jung H, Kishi Y. J. Am. Chem. Soc. 2016; 138: 7178
- 4d Konda S, Khatravath M, Mallurwar NK, Rao P, Sripelly S, Iqbal J, Arya P. Synthesis 2016; 48: 1663
- 4e Fukuyama T, Chiba H, Kroda H, Takigawa T, Kayano A, Tagami K. Org. Process Res. Dev. 2016; 20: 503
- 4f Choi H.-W, Fang FG, Fang H, Kim D.-S, Mathieu SR, Yu RT. Org. Lett. 2017; 19: 6092
- 4g Gaddam V, Nadella G, Sukumar G, Mainkar PS, Chandrasekhar S. Synthesis 2018; 50: 1901
- 4h Khatravath M, Mallurwar NK, Konda S, Gaddam J, Rao P, Iqbal J, Arya P. Tetrahedron Lett. 2019; 60: 150915
- 4i Lee H, Park Y, Jung H, Kim ST, Sin S, Ko E, Myeong I.-S, Moon H, Suhl CH, Jung Y, Jung E, Lee J, Lee K.-Y, Oh C.-Y, Song J, Yoon SH, Kang W, Jung J, Shin H. Tetrahedron 2019; 75: 4570
- 4j Mallurwar NK, Khatravath M, Konda S, Thatikonda T, Iqbal J, Arya P. ChemistrySelect 2021; 6: 798
- 4k Senapati S, Ramana CV. Org. Biomol. Chem. 2021; 19: 4542
- 5 Jain S, Vahdat LT. Clin. Cancer Res. 2011; 17: 6615
- 6a Shekhar C, Nasam R, Paipuri SR, Kumar P, Nayani K, Pabbaraja S, Mainkar PS, Chandrasekhar S. Tetrahedron Chem 2022; 4: 100033
- 6b Yasam BK, Pabbaraja S. SynOpen 2022; 6: 227
- 6c Nasam R, Pabbaraja S. Tetrahedron Lett. 2022; 97: 153777
- 6d Singh S, Nerella S, Pabbaraja S, Mehta G. Org. Lett. 2020; 22: 1575
- 6e Singh S, Samineni R, Pabbaraja S, Mehta G. Org. Lett. 2019; 21: 3372
- 6f Singh S, Samineni R, Pabbaraja S, Mehta G. Angew. Chem. Int. Ed. 2018; 57: 16847
- 6g Gantasala N, Borra S, Pabbaraja S. Eur. J. Org. Chem. 2018; 1230
- 7a Nakayama A, Kogure N, Kitajima M, Takayama H. Org. Lett. 2009; 11: 5554
- 7b Wu M.-J, Yeh J.-Y. Tetrahedron 1994; 50: 1073
- 7c Kumar SM, Prasad KR. Chem. Asian J. 2014; 9: 3431
- 7d Sharma A, Sudhakar A, Ghosh S. ACS Omega 2018; 3: 16563
- 7e Masayuki A, Tetsuya Y, Noriyuki K, Mariko K, Hiromitsu T. J. Am. Chem. Soc. 2014; 136: 11618
- 8 Akhil P, Dongeun K, Hyunsoo H. Org. Lett. 2018; 20: 756
- 9 Roldan S, Cardona A, Conesa L, Mura J, Falomir E, Carda M, Marco JA. Org. Biomol. Chem. 2017; 15: 220
- 10a Hanawa H, Hashimoto T, Mauroka K. J. Am. Chem. Soc. 2003; 125: 1708
- 10b DeFatima A, Kohn LK, Antonio MA, DeCarvalho JE, Pilli RA. Bioorg. Med. Chem. 2005; 13: 2927
- 10c Rao KN, Kumar K, Ghosh S. Eur. J. Org. Chem. 2018; 398
- 11 Brown HC. Tetrahedron 1961; 12: 117
- 12 Dess DB, Martin JC. J. Org. Chem. 1983; 48: 4155
- 13a Matsumura K, Hashiguchi S, Ikariya T, Noyori R. J. Am. Chem. Soc. 1997; 119: 8738
- 13b Yadav JS, Suresh B, Srihari P. Eur. J. Org. Chem. 2015; 5856
- 14a Shigemsa Y, Yasui M, Ohrai S, Sakaki M, Sashiwa H, Saimoto H. J. Org. Chem. 1991; 56: 910
- 14b Mahapatra S, Carter RG. Angew. Chem. Int. Ed. 2012; 51: 7948
- 15 Turks M, Vogel P. J. Org. Chem. 2009; 74: 435
- 16 Wittig G, Wetterling M.-H. Justus Liebigs Ann. Chem. 1947; 557: 193
- 17 Urbina A, Llor N, Barbieri MV, Bosch J, Amat M. Chem Commun. 2020; 56: 5536
- 18 Yadav JS, Sreenivasa M, Reddy SA, Reddy BV. S. J. Org. Chem. 2010; 75: 8307
The diastereomeric mixture was inseparable at this stage and was used further as such.